0001640455-15-000001.txt : 20150429 0001640455-15-000001.hdr.sgml : 20150429 20150429135417 ACCESSION NUMBER: 0001640455-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150429 DATE AS OF CHANGE: 20150429 EFFECTIVENESS DATE: 20150429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-238833 FILM NUMBER: 15811484 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVE. CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVE. CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0707 D LIVE 0001640455 Jounce Therapeutics, Inc. 1030 MASSACHUSETTS AVE. CAMBRIDGE MA MASSACHUSETTS 02138 857-259-3840 DELAWARE None None Corporation true 2012 Richard Murray 1030 Massachusetts Ave. Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Anna L. Barry 1030 Massachusetts Ave. Cambridge MA MASSACHUSETTS 02138 Executive Officer Kim C. Drapkin 1030 Massachusetts Ave. Cambridge MA MASSACHUSETTS 02138 Executive Officer Cary G. Pfeffer 1030 Massachusetts Ave. Cambridge MA MASSACHUSETTS 02138 Director Robert Kamen 1030 Massachusetts Ave. Cambridge MA MASSACHUSETTS 02138 Director Robert Tepper 1030 Massachusetts Ave. Cambridge MA MASSACHUSETTS 02138 Director Biotechnology Decline to Disclose 06b false 2015-04-17 false true false 0 56000000 56000000 0 Amount sold shown in item 13 and number of investors shown in item 14 include $10,000,000 from 2 non-US investors. false 14 0 0 0 false Jounce Therapeutics, Inc. Anna L. Barry Anna L. Barry VP of Legal & Secretary 2015-04-29